These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2234430)

  • 21. Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, gamma-interferon, and soluble interleukin 2 receptor (Mr 55,000 protein).
    List J; Moser RP; Steuer M; Loudon WG; Blacklock JB; Grimm EA
    Cancer Res; 1992 Mar; 52(5):1123-8. PubMed ID: 1737371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients.
    Barak V; Barak Y; Levine J; Nisman B; Roisman I
    J Basic Clin Physiol Pharmacol; 1995; 6(1):61-9. PubMed ID: 8562579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 concentrations in cerebrospinal fluid predict ventriculoperitoneal shunt infection.
    Asi-Bautista MC; Heidemann SM; Meert KL; Canady AI; Sarnaik AP
    Crit Care Med; 1997 Oct; 25(10):1713-6. PubMed ID: 9377887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Concentration of proinflammatory cytokines (TNF-alpha, IL-8) in the cerebrospinal fluid and the course of bacterial meningitis].
    Bociaga-Jasik M; Garlicki A; Kalinowska-Nowak A; Mach T
    Przegl Lek; 2004; 61(2):78-85. PubMed ID: 15230146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor-alpha and its soluble receptors in plasma and cerebrospinal fluid of multiple sclerosis patients treated with methylprednisolone.
    Franciotta D; Bergamaschi R; Martino G; Zardini E; Desina G; Cosi V
    Eur Cytokine Netw; 1999 Sep; 10(3):431-6. PubMed ID: 10477400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis.
    Chofflon M; Juillard C; Juillard P; Gauthier G; Grau GE
    Eur Cytokine Netw; 1992; 3(6):523-31. PubMed ID: 1296800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers.
    Alcocer-Varela J; Aleman-Hoey D; Alarcon-Segovia D
    Lupus; 1992 Feb; 1(2):111-7. PubMed ID: 1301962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy.
    Aly H; Khashaba MT; El-Ayouty M; El-Sayed O; Hasanein BM
    Brain Dev; 2006 Apr; 28(3):178-82. PubMed ID: 16181755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis.
    Scalabrino G; Galimberti D; Mutti E; Scalabrini D; Veber D; De Riz M; Bamonti F; Capello E; Mancardi GL; Scarpini E
    Brain Res; 2010 May; 1333():64-71. PubMed ID: 20347721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice.
    Lampa J; Westman M; Kadetoff D; Agréus AN; Le Maître E; Gillis-Haegerstrand C; Andersson M; Khademi M; Corr M; Christianson CA; Delaney A; Yaksh TL; Kosek E; Svensson CI
    Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12728-33. PubMed ID: 22802629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory response in bacterial meningitis: cytokine levels in the cerebrospinal fluid.
    Low PS; Lee BW; Yap HK; Tay JS; Lee WL; Seah CC; Ramzan MM
    Ann Trop Paediatr; 1995; 15(1):55-9. PubMed ID: 7598438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor in the cerebrospinal fluid of children with central nervous system leukemia.
    Ishii E; Ohga S; Murano I; Kobayashi M; Kimura K; Eguchi H; Akazawa K; Ueda K
    Leuk Res; 1991; 15(2-3):143-7. PubMed ID: 1901928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid interleukin-6, interleukin-8, and tumor necrosis factor-alpha in children with central nervous system infections.
    Tsai ML; Chen WC; Wang YC; Hung KL
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(1):16-21. PubMed ID: 8936005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement.
    Trysberg E; Carlsten H; Tarkowski A
    Lupus; 2000; 9(7):498-503. PubMed ID: 11035414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor Necrosis Factor-α, Interleukins-12(p40), 6, and 10 levels in cerebrospinal fluid and outcome prediction in Ossimi sheep with encephalitic listeriosis.
    Abdlla OA; Elboshy ME; Reisha EF; Gadlla HA; El-Khodery SA
    Cytokine; 2015 Jun; 73(2):283-7. PubMed ID: 25817420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-17 in transverse myelitis and multiple sclerosis.
    Graber JJ; Allie SR; Mullen KM; Jones MV; Wang T; Krishnan C; Kaplin AI; Nath A; Kerr DA; Calabresi PA
    J Neuroimmunol; 2008 May; 196(1-2):124-32. PubMed ID: 18417225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Concentrations of tumor necrosis factor alpha and interleukin-1 beta in cerebrospinal fluid in the course of tick-borne encephalitis].
    Kondrusik M; Hermanowska-Szpakowicz T; Jaroszewicz E
    Pol Merkur Lekarski; 1998 Mar; 4(21):126-9. PubMed ID: 9640061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.
    Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S
    J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytokine production by peripheral blood monocytes/macrophages in the patients with multiple sclerosis and its suppression by methylprednisolone].
    Imamura K; Hayashi F; Suzumura A
    Rinsho Shinkeigaku; 1992 Mar; 32(3):276-80. PubMed ID: 1628450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.